| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.52 | 0.005 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.005 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.005 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.097 | 0.005 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.096 | 0.005 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.006 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.006 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.007 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.098 | 0.007 |